(Press-News.org) Chronic subdural hematoma (CSDH) is one of the most common neurosurgical conditions, particularly among the elderly, with an annual incidence ranging from 1.7 to 20.6 per 100,000 people. As the global population ages and the use of antiplatelet and anticoagulant therapies increases, the incidence of CSDH is projected to rise significantly. Despite its clinical prevalence, treatment options have seen limited breakthroughs over the past two decades, largely due to an incomplete understanding of its pathophysiology. This review provides a comprehensive overview of the epidemiology, pathogenesis, diagnostic approaches, and evolving treatment strategies for CSDH, with a special focus on the emerging role of middle meningeal artery embolization (MMAE).
Epidemiology of CSDH
CSDH is the second most common neurosurgical disease and is especially prevalent in the elderly, with rates as high as 127.1 per 100,000 among those over 80 years old. The increasing use of anticoagulant and antiplatelet medications, combined with a higher risk of falls in the aging population, contributes to its growing burden. By 2030, CSDH is expected to surpass brain tumors as the most frequent condition in cranial surgery. Recurrence remains a significant challenge, affecting approximately 10% of surgically treated patients, with risk factors including advanced age, anticoagulant use, male gender, and poor postoperative brain re-expansion.
Etiology and Pathogenesis
The development of CSDH involves a complex interplay of traumatic, inflammatory, and angiogenic mechanisms. While traditional models emphasized bridging vein rupture, recent biomechanical studies suggest this may not fully explain non-traumatic cases. Instead, current evidence highlights the role of dural border cell layer injury, leading to inflammation, fibrinolytic dysregulation, and neovascularization. Key mediators such as vascular endothelial growth factor (VEGF) and pro-inflammatory cytokines (e.g., IL-6, IL-8) drive membrane formation and recurrent microbleeds from fragile neovessels. This self-perpetuating cycle of inflammation and angiogenesis underpins the chronicity and recurrence of CSDH.
Radiographic Diagnosis
Computed tomography (CT) remains the primary imaging modality for CSDH, typically revealing hypodense, isodense, or mixed-density crescentic collections. However, CT has limitations in detecting small or isodense hematomas and in characterizing internal architecture. Magnetic resonance imaging (MRI) offers superior soft-tissue resolution, enabling better visualization of septations and membrane structures, which can help predict recurrence risk. Advanced MRI techniques, including diffusion-weighted imaging, are increasingly used to assess hematoma maturity and guide treatment planning.
Treatment of CSDH
Surgical Interventions
Surgery is the mainstay for symptomatic CSDH or cases with significant mass effect. Common techniques include:
Twist-drill craniostomy (TDC): Minimally invasive, bedside-appropriate, but associated with higher recurrence and risks of cortical injury.
Burr-hole craniostomy (BHC): The most widely used method, with high efficacy and low morbidity, though recurrence remains a concern. Technical variations—such as irrigation fluid type, patient positioning, and drainage location (subdural vs. subgaleal)—are areas of ongoing debate.
Craniotomy: Reserved for complex, recurrent, or organized hematomas, but carries higher complication and mortality rates.
Endoscopic-assisted evacuation: Allows direct visualization and complete membrane removal, potentially reducing recurrence, though it requires expertise and may prolong operative time.
Middle Meningeal Artery Embolization (MMAE)
MMAE has emerged as a promising minimally invasive intervention that targets the neovascularization responsible for CSDH persistence and recurrence. By embolizing the middle meningeal artery, blood supply to the hematoma membranes is reduced, promoting resolution. MMAE can be used as a primary treatment or as an adjuvant to surgery, particularly in high-risk patients, such as those on anticoagulants or with recurrent CSDH. Studies report recurrence rates as low as 4.3% with MMAE, though its role in acute symptom relief remains limited.
Non-Surgical and Pharmacological Management
For asymptomatic or high-risk patients, conservative management is an option. Pharmacologic therapies aim to modulate inflammation and angiogenesis:
Atorvastatin: Reduces inflammation and promotes vascular repair, showing promise in reducing hematoma volume and recurrence.
Corticosteroids: Potent anti-inflammatory agents, but evidence of efficacy is mixed, and long-term use carries significant side effects.
Tranexamic acid (TXA): An antifibrinolytic agent that may reduce rebleeding, though its safety in elderly patients requires further study.
ACE Inhibitors: Controversial due to conflicting data on their effect on angiogenesis and recurrence.
Herbal Medicine: Preliminary studies suggest agents like Goreisan may reduce recurrence, though clinical evidence remains limited.
Future Directions
Despite advances, CSDH management is hampered by a lack of standardized protocols and limited high-quality evidence. Future efforts should focus on:
Clarifying pathophysiological mechanisms to enable targeted therapies.
Validating the efficacy and safety of MMAE through randomized trials.
Developing consensus on surgical techniques and perioperative care.
Exploring combination therapies, such as statins with corticosteroids or MMAE with minimally invasive surgery.
Conclusion
CSDH is a dynamically evolving field in neurosurgery. While surgical evacuation remains the cornerstone of treatment, recurrence and complication rates underscore the need for improved strategies. MMAE represents a paradigm shift, offering a targeted, minimally invasive alternative. Pharmacological interventions and enhanced imaging techniques further enrich the therapeutic landscape. Future research must prioritize mechanistic insights and multidisciplinary collaboration to optimize outcomes for this increasingly prevalent condition.
Full text:
https://xiahepublishing.com/3067-6150/NSSS-2025-00023
The study was recently published in the Neurosurgical Subspecialties.
Neurosurgical Subspecialties (NSSS) is the official scientific journal of the Department of Neurosurgery at Union Hospital of Tongji Medical College, Huazhong University of Science and Technology. NSSS aims to provide a forum for clinicians and scientists in the field, dedicated to publishing high-quality and peer-reviewed original research, reviews, opinions, commentaries, case reports, and letters across all neurosurgical subspecialties. These include but are not limited to traumatic brain injury, spinal and spinal cord neurosurgery, cerebrovascular disease, stereotactic radiosurgery, neuro-oncology, neurocritical care, neurosurgical nursing, neuroendoscopy, pediatric neurosurgery, peripheral neuropathy, and functional neurosurgery.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
A Japanese research team has studied the variations in beryllium-7 concentrations in the surface air over the Antarctic regions of Southern Ocean. Beryllium-7 is a radioactive isotope of beryllium produced by cosmic rays in the atmosphere. The team explored, over space and time, how the beryllium-7 is transported from the atmosphere to the Earth’s surface. Their goal was to better understand the mechanisms of atmospheric mixing on Earth.
Their research is published in the Journal of Geophysical Research: Atmospheres on October 14, 2025.
“We aimed to clarify where and by what atmospheric flows the radioactive isotope beryllium-7, produced in the stratosphere ...
SAN ANTONIO — November 18, 2025 — Southwest Research Institute identified a security vulnerability in a standard protocol governing communications between electric vehicles (EV) and EV charging equipment. The research prompted the Cybersecurity & Infrastructure Security Agency (CISA) to issue a security advisory related to the ISO 15118 vehicle-to-grid communications standard.
Through internal research, a team of SwRI engineers spoofed signal measurements between an EV and EV supply equipment (EVSE), leading to CISA’s publication of a Common ...
Operating a new device named the Fusion Z-pinch Experiment 3, or FuZE-3, Zap Energy has now achieved plasmas with electron pressures as high as 830 megapascals (MPa), or 1.6 gigapascals (GPa) total, comparable to the pressures found deep below Earth’s crust. The results are the highest-pressure performance to date in a sheared-flow-stabilized Z pinch and an important marker on the path to scientific energy gain, or Q>1.
FuZE-3 is Zap’s first device to incorporate a third electrode to separate the forces that drive plasma acceleration and compression. Details of the preliminary results were presented today at the American Physical Society’s Division of Plasma ...
Washington, November 18, 2025—Students who enroll in short-term, job-focused training through community college noncredit programs experience modest but meaningful earnings gains and a greater likelihood of being employed after training, according to a new study published today in Educational Evaluation and Policy Analysis, a peer-reviewed journal of the American Educational Research Association.
The study, conducted by Peter Riley Bahr of the Strada Institute for the Future of Work and Rooney Columbus of E&E Analytics, finds that workers earn about $2,000 more per year, on average, within two years of ...
November 18, 2025 – The American Pediatric Society (APS) is pleased to announce Tara O. Henderson, MD, MPH, as the recipient of the 2026 Norman J. Siegel New Member Outstanding Science Award, in recognition of her significant contributions to pediatric science. The award will be presented to Dr. Henderson during the APS Presidential Plenary at the Pediatric Academic Societies 2026 Meeting, taking place in Boston, MA, April 24-27.
Established in honor of renowned nephrologist Norman J. Siegel, MD, FASN, the award celebrates early-career APS members whose scientific work demonstrates ...
Alzheimer’s disease (AD) is a devastating cause of memory loss and cognitive decline, for which no curative treatment is available. Among lifestyle factors, physical activity stands out as possibly one of the strongest defenders of brain health.
Growing evidence links skeletal muscle function to cognitive health. Pioneering research from Florida Atlantic University and its collaborators at the Novo Nordisk Foundation Center for Basic Metabolic Research takes this evidence to the next level, revealing that the key to fighting AD may lie not just in the brain – but also in our muscles.
At the center of this discovery is Cathepsin ...
A study published in Strategic Management Journal sheds light on the subtle yet significant role that unelected officials play in helping corporations secure successful contract bids.
The research, led by Dr. Tony L. He of Rutgers Business School in Newark, N.J., analyzed a dataset of 14,849 public procurement contracts across 28 European countries between 2011 and 2017.
“My research shows that, contrary to what many might expect, in this particular context it’s not the flashy connections to powerful elected officials that help firms most,” Dr. He explained. “Instead, ...
In a Perspective, the authors suggest that the social and humanitarian impacts of overshooting the Paris Agreement’s aspirational goal of a 1.5 degrees Celsius rise in global mean temperature remain largely unknown, despite robust knowledge of physical climate impacts. Andrew Kruczkiewicz and colleagues outline five factors that policymakers and planners should take into account when considering the human impacts of climate overshoot: peak warming and duration of overshoot, localized amplification of effects, timing of arrival, adaptation limits, and dynamics of overshoot reversal. The ...
LOS ANGELES – The 2026 Optical Fiber Communications Conference and Exhibition (OFC), the premier global event for optical communications and networking, will be held 15 – 19 March 2026, at the Los Angeles Convention Center in Los Angeles, California, USA.
The centerpiece of the conference’s technical program is the Plenary Session, which will feature four industry luminaries: Alexis Bjorlin, Senior Vice President and General Manager for DGX Cloud, NVIDIA, USA; Julie Sheridan Eng, Chief Technology Officer, Coherent, USA; Siegbert Martin, Chief ...
A machine learning framework can distinguish molecules made by biological processes from those formed through non-biological processes and could be used to analyze samples returned by current and future planetary missions. José C. Aponte, Amirali Aghazadeh, and colleagues analyzed eight carbonaceous meteorites and ten terrestrial geologic samples using two-dimensional gas chromatography coupled with high-resolution time-of-flight mass spectrometry. Using this data, the authors developed LifeTracer, a computational ...
